ICON plc to Present at 38th Annual J.P. Morgan Healthcare Conference and Issue Financial Guidance for Full Year 2020
January 13 2020 - 08:30AM
Business Wire
ICON plc, (NASDAQ: ICLR) a global provider of drug and device
development and commercialisation services to pharmaceutical,
biotechnology, medical device and government and public health
organisations, today announced that Dr. Steve Cutler, CEO and Mr.
Brendan Brennan, CFO of ICON plc, will present at 38th Annual J.P.
Morgan Healthcare Conference on Tuesday, January 14, 2020. The
presentation will be webcast live from 10.30am PST. ICON’s
financial guidance for the year ended December 31, 2020 will be
released by press release on Tuesday, January 14, 2020 prior to the
presentation and will be discussed during the presentation.
A link to the live webcast will be available via the Investor
section of our website under “Events”.
About ICON plc
ICON plc is a global provider of outsourced drug and device
development and commercialisation services to pharmaceutical,
biotechnology, medical device and government and public health
organisations. The company specialises in the strategic
development, management and analysis of programs that support
clinical development - from compound selection to Phase I-IV
clinical studies. With headquarters in Dublin, Ireland, ICON
operates from 99 locations in 40 countries and had approximately
14,600 employees as at September 30, 2019. Further information is
available at www.iconplc.com.
This press release contains forward-looking statements. These
statements are based on management's current expectations and
information currently available, including current economic and
industry conditions. These statements are not guarantees of future
performance or actual results, and actual results, developments and
business decisions may differ from those stated in this press
release. The forward-looking statements are subject to future
events, risks, uncertainties and other factors that could cause
actual results to differ materially from those projected in the
statements, including, but not limited to, the ability to enter
into new contracts, maintain client relationships, manage the
opening of new offices and offering of new services, the
integration of new business mergers and acquisitions, as well as
economic and global market conditions and other risks and
uncertainties detailed from time to time in SEC reports filed by
ICON, all of which are difficult to predict and some of which are
beyond our control. For these reasons, you should not place undue
reliance on these forward-looking statements when making investment
decisions. The word "expected" and variations of such words and
similar expressions are intended to identify forward-looking
statements. Forward-looking statements are only as of the date they
are made and we do not undertake any obligation to update publicly
any forward-looking statement, either as a result of new
information, future events or otherwise. More information about the
risks and uncertainties relating to these forward-looking
statements may be found in SEC reports filed by ICON, including its
Form 20-F, F-1, S-8 and F-3, which are available on the SEC's
website at http://www.sec.gov.
Source: ICON plc
ICON/ICLR-G
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200113005510/en/
Investor Relations +1888 381 7923 or Jonathan Curtain Vice
President Corporate Finance and Investor Relations +353 1 291
2000
ICON (NASDAQ:ICLR)
Historical Stock Chart
From Feb 2024 to Mar 2024
ICON (NASDAQ:ICLR)
Historical Stock Chart
From Mar 2023 to Mar 2024